Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Thumbnail

Is gastric bypass more beneficial for diabetes patients than traditional weight loss?

The research, published in the New England Journal of Medicine, compared patients with diabetes who lost weight after gastric bypass surgery with those who lost it by changing their diet. 

Thumbnail

Eating chocolate linked to healthier blood vessels, lower risk of CAD

Eating chocolate—in moderation, of course—is associated with a reduced risk of coronary artery disease (CAD), according to new findings published in the European Journal of Preventive Cardiology.

Thumbnail

Eat your vegetables, help your heart: How plant-based diets can boost cardiovascular health

Two separate research teams have highlighted the benefits of limiting meat consumption and adopting a plant-based diet. 

Thumbnail

Statin use helps elderly patients live longer, healthier lives

Statin use can lower an older patient’s risk of all-cause and cardiovascular mortality, according to a new study of more than 325,000 U.S. veterans.

Thumbnail

What decades-old dietary recommendations for high cholesterol get wrong

Patients diagnosed with familiar hypercholesterolemia should work to lower carbohydrates, not saturated fats, according to a new study published in BMJ Evidence-Based Medicine.

Thumbnail

Common blood pressure medications may reduce colorectal cancer risk

The use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) is associated with a lower risk of colorectal cancer.

Thumbnail

Healthy older patients see benefits from statin use

Statin use may help healthy older patients avoid physical disability and cardiovascular disease, according to new data published in the Journal of the American College of Cardiology.

FDA approves new fast-acting insulin for type 1 and type 2 diabetes

The approval was based on data from two phase III randomized, treat-to-target studies.